Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 22.11 | N/A |
| PEG Ratio (TTM) | -1.65 | N/A |
| P/S Ratio (TTM) | 1.84 | N/A |
| P/B Ratio (TTM) | 3.53 | N/A |
| P/FCF Ratio (TTM) | 9.77 | N/A |
| Price to 5YR AVG Earnings Ratio | 70.30 | N/A |
| Price to 5YR AVG FCF Ratio | 13.74 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 12.04% | N/A |
| ROE (TTM) | 16.02% | N/A |
| Net Profit Margin (TTM) | 8.48% | N/A |
| ROIC 5YR AVG | 6.26% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 17.14% | 45.31% | 62.51% |
| Revenue | 1.15% | 3.95% | 7.91% |
| Net Income | 17.13% | 43.53% | 59.01% |
| Cash Flow | 19.94% | 11.49% | 16.83% |
Health (79%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.46 | N/A |
| Quick Ratio (TTM) | 3.46 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 27.70 | N/A |
| Piotroski F-Score | 9 | N/A |
| Altman Z-Score | 7.25 | N/A |
| LTL to 5YR AVG FCF | 0.52 | N/A |
| Shares Outstanding Growth 5YR AVG | -4.65% | N/A |